Biotech · Private company
Medidata Solutions
Track this companyFree. Adds Medidata Solutions to your Dealase workspace and tells you when its record changes.
Clinical trials125 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials12
- Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)PHASE2 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07881952 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)PHASE3 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07637734 · fetched Nov 12, 2026
- Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)PHASE3 · RECRUITING · started Mar 11, 2026ClinicalTrials.gov NCT07457918 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT07246590 · fetched Nov 12, 2026
- Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.PHASE3 · COMPLETED · started Jul 1, 2022ClinicalTrials.gov NCT05267613 · fetched Nov 12, 2026
- Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and HyperkalaemiaCOMPLETED · started Oct 23, 2020ClinicalTrials.gov NCT04566653 · fetched Nov 12, 2026
- Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP SystemNA · ACTIVE_NOT_RECRUITING · started Jun 12, 2020ClinicalTrials.gov NCT04201132 · fetched Nov 12, 2026
- Durvalumab Long-Term Safety and Efficacy StudyPHASE4 · COMPLETED · started Sep 5, 2019ClinicalTrials.gov NCT04078152 · fetched Nov 12, 2026
- An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.PHASE3 · TERMINATED · started Apr 11, 2019ClinicalTrials.gov NCT03775421 · fetched Nov 12, 2026
- A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular DiseasePHASE2 · TERMINATED · started Dec 7, 2018ClinicalTrials.gov NCT03714815 · fetched Nov 12, 2026
- First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-CisplatinPHASE3 · COMPLETED · started Jan 7, 2010ClinicalTrials.gov NCT00981058 · fetched Nov 12, 2026
- First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-CisplatinPHASE3 · COMPLETED · started Nov 2, 2009ClinicalTrials.gov NCT00982111 · fetched Nov 12, 2026